BLEN DANIEL: Open Payments
NPI 1285286492 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,228 in 101 payments from 18 companies in 2025. Trend: 2023 $2,740 · 2024 $3,142 · 2025 $3,228
Food & beverage: $3,228
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 4 | $502 |
| Abbott Laboratories | 7 | $402 |
| AstraZeneca Pharmaceuticals LP | 11 | $325 |
| Merck Sharp & Dohme LLC | 12 | $274 |
| Kestra Medical Technology Services, Inc. | 5 | $266 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $232 |
| BridgeBio Pharma, Inc. | 7 | $230 |
| Novo Nordisk Inc | 6 | $152 |
| GENZYME CORPORATION | 2 | $148 |
| Alnylam Pharmaceuticals Inc. | 6 | $141 |
Products named: Barostim Neo System, CARDIOMEMS, Assure WCD, JARDIANCE, Attruby, VERQUVO, CAMZYOS, Kerendia.
Industry payments across TX — which companies pay providers there.
